Ashland vs Chemours

This page compares Ashland and Chemours, examining their business models, financial performance, and market context to provide a neutral, accessible view for readers. Educational content, not financial advice.

About The Companies

Ashland (ASH)

Chemours (CC)

Chemours Company (CC) is a US-based chemicals manufacturer known for titanium dioxide (TiO2) pigments, fluoroproducts (including refrigerants and specialty fluorochemicals) and performance chemicals. With a market capitalisation around $2.0 billion, the group serves coatings, automotive, industrial and refrigeration markets worldwide. Key drivers include global industrial and construction activity, raw-material and energy costs, product mix and pricing for commodity chemicals. Investors should note exposure to cyclical end markets, volatile input costs and material regulatory and environmental scrutiny associated with certain fluorochemicals. The company has pursued operational improvements and portfolio management to stabilise cash flow, but outcomes can vary. This summary is for educational purposes only and not personalised investment advice; values can rise and fall and past performance does not guarantee future results. Consider your risk tolerance and seek professional advice if unsure about suitability.

Comparison Snapshot

Key Financial Metrics

ASH

Metric

$2.72B

Market Cap

$1.80B

15.62%

Potential Profit

30.56%

Buy

Analyst Rating

Buy

Which Baskets Do They Appear In?

No baskets available in this category

Which Baskets Do They Appear In?

No baskets available in this category

Investment Analysis

Ashland

ASH

Pros

Ashland has successfully expanded its adjusted EBITDA margin by 110 basis points to 24.9% despite a sales decline, showing effective cost management and portfolio optimisation.
The company maintains stable underlying organic volumes in a challenging market, indicating resilience in core demand.
Ashland's Personal Care segment showed organic sales growth of 5% ex-divestiture in Q4 2025, reflecting strength in end markets.

Considerations

Ashland reported an 8% decline in Q4 2025 sales to $478 million and a 14% sales decline for full fiscal 2025 to $1.824 billion, impacted by portfolio divestitures.
Fiscal 2025 recorded a net loss of $845 million due mainly to significant goodwill impairments and sale impacts, raising concerns about asset valuation and profitability.
Cash flow from operations and free cash flow decreased notably in Q4 2025 compared to prior year, signaling potential liquidity or operational pressures.

Chemours

Pros

Chemours benefits from a strong portfolio of titanium dioxide and chemical products with global market presence, supporting revenue stability.
The company has taken steps to reduce debt and strengthen its balance sheet in recent quarters, improving financial flexibility.
Chemours is exposed to growth in specialty chemicals demand in automotive and electronics sectors, offering growth potential in higher-margin segments.

Considerations

Chemours faces ongoing cyclicality and commodity price volatility risks due to its exposure to raw materials and global industrial markets.
Environmental and regulatory compliance costs remain substantial, impacting margins and requiring continuous capital expenditures.
Recent profit margins have been pressured by rising input costs and competitive pricing dynamics in core product lines.

Why invest with Nemo?

🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Comparisons

Ashland vs FMC

Ashland vs FMC: stock comparison

Ashland vs Chemours

About The Companies

Comparison Snapshot

Which Baskets Do They Appear In?

Which Baskets Do They Appear In?